Scopus BioPharma - M&A Summary and Business Overview

Life ScienceCompany

Scopus BioPharma M&A Summary

Scopus BioPharma has acquired 1 company, including 1 in the last 5 years.

Scopus BioPharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Scopus BioPharma Business Overview

Where is Scopus BioPharma headquartered?

Scopus BioPharma is headquartered in New York, New York.

How many employees does Scopus BioPharma have?

Scopus BioPharma has 1 employees.

What sector is Scopus BioPharma in?

Scopus BioPharma is a life science company.

When was Scopus BioPharma founded?

Scopus BioPharma was founded in 2017.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Scopus BioPharma

Scopus BioPharma, Inc.

420 Lexington Avenue,
New York, New York 10170
United States,
(212) 479-2513
www.scopusbiopharma.com

Scopus BioPharma is a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. To achieve its mission, the company seeks to capitalize on ground-breaking scientific and medical discoveries at some of the world’s foremost academic and research institutions. Scopus BioPharma was formed in 2017 and is based in New York, New York.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - - 1 - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Olimmune, Inc. 2021-06-30 - Add-on Acquisition
Los Angeles, California · www.olimmune.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  California 1 - - -
Total 1 - - -

 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.